Citius Pharmaceuticals Inc (CTXR) earnings · $13.4M cap
These earnings events as JSON? API free 100/dayCitius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
This CTXR earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CTXR revenue for 2026-06-30 was $1.5M. Net income was -$11.9M. Revenue was down 10.4% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
When the next CTXR 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 10.4% from 2026-03-31 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full CTXR research stays on the stock page; the tape stays on the quote page.
CTXR earnings FAQ
What are CTXR's latest revenue and net income?
Latest cached Citius Pharmaceuticals Inc (CTXR) revenue for Jun 30, 2026 was $1.5M. Net income was -$11.9M. Statements: https://lician.com/financials/ctxr
What is CTXR's latest diluted EPS?
Latest cached Citius Pharmaceuticals Inc (CTXR) diluted EPS for Jun 30, 2026 was -$0.34.
What period does the latest CTXR earnings print cover?
The latest cached Citius Pharmaceuticals Inc (CTXR) earnings print covers Jun 30, 2026. The prior cached period on this page is Mar 31, 2026.
How did CTXR revenue change from the prior cached period?
Cached Citius Pharmaceuticals Inc (CTXR) revenue was down 10.4% from $1.7M (Mar 31, 2026) to $1.5M (Jun 30, 2026). Statements: https://lician.com/financials/ctxr
Where are CTXR earnings listed?
Cached earnings facts for Citius Pharmaceuticals Inc (CTXR) are listed at https://lician.com/earnings/ctxr. Statements: https://lician.com/financials/ctxr
Not investment advice.